Overview
No overview information available.
Background
No background information available.
Indication
用于治疗二线以上复发或难治性经典型霍奇金淋巴瘤（r/r cHL）患者。
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2025/01/06 | Phase 1 | Recruiting | |||
2024/12/11 | Phase 2 | Recruiting | |||
2024/08/01 | Phase 1 | Recruiting | |||
2024/05/28 | Phase 3 | Recruiting | Fundación GECP | ||
2024/02/08 | Phase 2 | Recruiting | |||
2024/02/02 | Phase 1 | Recruiting | |||
2023/12/12 | Phase 2 | Not yet recruiting | Shanghai Zhongshan Hospital | ||
2023/12/04 | Phase 2 | Recruiting | |||
2023/11/15 | Phase 2 | Recruiting | Fundación para el Progreso de la Oncología en Cantabria | ||
2023/11/13 | Phase 2 | Not yet recruiting | Obstetrics & Gynecology Hospital of Fudan University |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| Zimberelimab Injection | 国药准字S20210034 | 生物制品 | 注射剂 | 8/25/2021 |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||